Mobile Diagnostic and Communication Tools:
- Eye Netra, a low-cost app Designed to replace auto refractor.
- Massachusetts Eye and Ear developed a simple technique of fundus (retinal) photography using an I phone and an inexpensive app.
- A surgeon wearing Google Glass performed the world’s first surgery.
- Virtual reality augmentation tool-Future surgical training tool.
- Femtosecond laser surgery
- Robotics may soon be used in vitreoretinal surgery
- Lead to earlier and better treatment of eye-related ailments like diabetic retinopathy and retinitis pigmentosa.
- FDA approved the use of Argus II, a bionic eye and The Atlas IMS – the first fully implantable, wirelessly controlled retinal prosthetic.
Allow the patients with retinitis pigmentosa and age related macular degeneration to see in black white.
- Transplant of a biosynthetic cornea occurred in 2010. It helps restore sight in the vast number of people who are currently waiting for a donated human cornea for transplantation.
- Researchers at the University of Dayton Research Institute recently created “fuzzy fiber” carbon nanotubes.
- Fuzzy Fibers are biocompatible and can help prevent the build-up of firbroblasts.
- It has a role in the treatment of Glaucoma and Macular degeneration.
Stem Cell Advances
- Innovative stem cell treatment – It has developed had corrected the eyesight of an individual with vision 20/400 vision to 20/40.
- Has a role in the treatment of Stargardt’s macular dystrophy.
Refractive Surgery and IOLs – Future Trends.
Accommodating IOL Channel-
- Patients after lens implantation will be able to achieve the vision of 20 to 40 year old emmetropic patient.
- Lens implants will be accommodating biconvex, 9 mm in diameter, customized and repeatedly adjustable in power, toricity and higher – order aberration, and insertable through a 1 – to 2 –mm incision.
- Multiple laser delivery systems and surgical interventions will be controlled through computer software and robotics.
- By 2100 genetic engineering will eliminate emetropia.
- Genetic testing of pregnant women and infants followed by gene modifying treatments that prevent the development of ametropias.